Lawmakers Fight FDA's Anti-Estriol Stance

Law360, New York (May 8, 2008, 12:00 AM EDT) -- In the wake of the U.S. Food and Drug Administration's backlash against bioidentical hormone replacement drugs, lawmakers introduced a resolution Tuesday opposing the agency's policy restricting women's access to the products.

The bipartisan motion, introduced in the U.S. House of Representatives by Rep. Mike Ross (D-Ark.), is intended to express the sense of Congress that the FDA's new policy restricting women's access to medications containing estriol – a weaker form of the hormone estrogen – “does not serve the public interest” and urging the agency to...
To view the full article, register now.